Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beatriz Perdiguero

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Viruses|April 9, 2015
The evolution of poxvirus vaccinesLucas Sánchez-Sampedro, Beatriz Perdiguero, Ernesto Mejías-Pérez, et al.
The Journal of General Virology|October 1, 2013
New vaccinia virus promoter as a potential candidate for future vaccinesMauro Di Pilato, Ernesto Mejías-Pérez, Carmen Elena Gómez, et al.
Plos Pathogens|November 19, 2013
Involvement of the cellular phosphatase DUSP1 in vaccinia virus infectionAna Cáceres, Beatriz Perdiguero, Carmen E Gómez, et al.
Vaccines|July 3, 2019
Induction of Broad and Polyfunctional HIV-1-Specific T Cell Responses by the Multiepitopic Protein TMEP-B Vectored by MVA VirusBeatriz Perdiguero, Cristina Sánchez-Corzo, Carlos Oscar S Sorzano, et al.
Viruses|February 21, 2019
A Novel MVA-Based HIV Vaccine Candidate (MVA-gp145-GPN) Co-Expressing Clade C Membrane-Bound Trimeric gp145 Env and Gag-Induced Virus-Like Particles (VLPs) Triggered Broad and Multifunctional HIV-1-Specific T Cell and Antibody ResponsesBeatriz Perdiguero, Cristina Sánchez-Corzo, Carlos Oscar S Sorzano, et al.
Journal of Virology|March 16, 2012
Removal of vaccinia virus genes that block interferon type I and II pathways improves adaptive and memory responses of the HIV/AIDS vaccine candidate NYVAC-C in miceCarmen Elena Gómez, Beatriz Perdiguero, Jose Luis Nájera, et al.
Viruses|August 15, 2018
Potent HIV-1-Specific CD8 T Cell Responses Induced in Mice after Priming with a Multiepitopic DNA-TMEP and Boosting with the HIV Vaccine MVA-BBeatriz Perdiguero, Suresh C Raman, Cristina Sánchez-Corzo, et al.
Journal of Virology|April 19, 2013
High, broad, polyfunctional, and durable T cell immune responses induced in mice by a novel hepatitis C virus (HCV) vaccine candidate (MVA-HCV) based on modified vaccinia virus Ankara expressing the nearly full-length HCV genomeCarmen E Gómez, Beatriz Perdiguero, María Victoria Cepeda, et al.
Plos One|September 27, 2013
Deletion of the vaccinia virus gene A46R, encoding for an inhibitor of TLR signalling, is an effective approach to enhance the immunogenicity in mice of the HIV/AIDS vaccine candidate NYVAC-CBeatriz Perdiguero, Carmen Elena Gómez, Mauro Di Pilato, et al.
Journal of Virology|October 29, 2020
Enhancement of HIV-1 Env-Specific CD8 T Cell Responses Using Interferon-Stimulated Gene 15 as an Immune AdjuvantCarmen Elena Gómez, Beatriz Perdiguero, Michela Falqui, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Viruses|April 9, 2015
The evolution of poxvirus vaccinesLucas Sánchez-Sampedro, Beatriz Perdiguero, Ernesto Mejías-Pérez, et al.
The Journal of General Virology|October 1, 2013
New vaccinia virus promoter as a potential candidate for future vaccinesMauro Di Pilato, Ernesto Mejías-Pérez, Carmen Elena Gómez, et al.
Plos Pathogens|November 19, 2013
Involvement of the cellular phosphatase DUSP1 in vaccinia virus infectionAna Cáceres, Beatriz Perdiguero, Carmen E Gómez, et al.
Vaccines|July 3, 2019
Induction of Broad and Polyfunctional HIV-1-Specific T Cell Responses by the Multiepitopic Protein TMEP-B Vectored by MVA VirusBeatriz Perdiguero, Cristina Sánchez-Corzo, Carlos Oscar S Sorzano, et al.
Viruses|February 21, 2019
A Novel MVA-Based HIV Vaccine Candidate (MVA-gp145-GPN) Co-Expressing Clade C Membrane-Bound Trimeric gp145 Env and Gag-Induced Virus-Like Particles (VLPs) Triggered Broad and Multifunctional HIV-1-Specific T Cell and Antibody ResponsesBeatriz Perdiguero, Cristina Sánchez-Corzo, Carlos Oscar S Sorzano, et al.
Journal of Virology|March 16, 2012
Removal of vaccinia virus genes that block interferon type I and II pathways improves adaptive and memory responses of the HIV/AIDS vaccine candidate NYVAC-C in miceCarmen Elena Gómez, Beatriz Perdiguero, Jose Luis Nájera, et al.
Viruses|August 15, 2018
Potent HIV-1-Specific CD8 T Cell Responses Induced in Mice after Priming with a Multiepitopic DNA-TMEP and Boosting with the HIV Vaccine MVA-BBeatriz Perdiguero, Suresh C Raman, Cristina Sánchez-Corzo, et al.
Journal of Virology|April 19, 2013
High, broad, polyfunctional, and durable T cell immune responses induced in mice by a novel hepatitis C virus (HCV) vaccine candidate (MVA-HCV) based on modified vaccinia virus Ankara expressing the nearly full-length HCV genomeCarmen E Gómez, Beatriz Perdiguero, María Victoria Cepeda, et al.
Plos One|September 27, 2013
Deletion of the vaccinia virus gene A46R, encoding for an inhibitor of TLR signalling, is an effective approach to enhance the immunogenicity in mice of the HIV/AIDS vaccine candidate NYVAC-CBeatriz Perdiguero, Carmen Elena Gómez, Mauro Di Pilato, et al.
Journal of Virology|October 29, 2020
Enhancement of HIV-1 Env-Specific CD8 T Cell Responses Using Interferon-Stimulated Gene 15 as an Immune AdjuvantCarmen Elena Gómez, Beatriz Perdiguero, Michela Falqui, et al.
Pageof 7